In this episode of From Lab to Patient, Garage to Market, Philip Crowley speaks with Debbie Hart, who worked alongside New Jersey’s biopharmaceutical industry leaders to establish BioNJ in 1994. Ms. Hart is recognized as a respected thought leader and influential advocate. Under Ms. Hart’s leadership, BioNJ has become the trusted voice of the life sciences industry in New Jersey – working directly with legislative leaders in both Trenton and Washington D.C. to advance the life sciences industry, foster medical innovation and patient access while ensuring health equity and healthcare affordability. Most recently, she was named by Governor Murphy as the Chair of the New Jersey Commission on Science, Innovation and Technology. Tune in to the episode to hear about:
- The growth and impact of BioNJ, a leading trade organization for life sciences companies in New Jersey, and the importance of industry collaboration and government support.
- The challenges faced by startups in the life sciences industry, including long development timelines and significant fundraising needs, while emphasizing the importance of perseverance and creativity
- BioNJ offers extensive resources and support for its members, including networking events, policy advocacy, financial savings programs, and workforce development initiatives
- The importance of good legal representation for startups to ensure compliance and attractiveness to potential investors and strategic partners, while BioNJ’s efforts contribute to advancing biotechnology on a global scale.